Mood disorders are common, recurrent and disabling illnesses which are freq
uently associated with hypothalamic-pituitary-adrenal (HPA) axis dysregulat
ion and memory loss. The hippocampus provides negative feedback to the HPA
axis and has an important role in key aspects of spatial and declarative me
mory. Thus, hippocampal dysfunction could account for both the memory impai
rment and neuroendocrine abnormalities found in moos disorders. The critica
l role of the hippocampus in declarative memory, emotional processing, and
vulnerability and human studies. Cellular processes in the hippocampus incl
uding long-term potentiation, neurogenesis, and dendritic remodeling are cu
rrently areas of intense study. Human studies report cognitive impairment c
onsistent with hippocampal dysfunction in depression, bipolar disorder, Cus
hing's disease, and in those individuals receiving exogenous corticosteroid
s. This review examines the role of the corticosteroids in hippocampal remo
deling and atrophy in patients with mood disorders. Interventions to preven
t or reverse the damaging effects of corticosteroids on the hippocampus are
discussed. (C) 1999 American College of Neuropsychopharmacology. Published
by Elsevier Science Inc.